Company: NCNA
Filing Date: 2025-04-24
Form Type: F-1
Source: 0001193125-25-092131
Chunk: 6

Company: NuCana plc
Filing Date: 2025-04-24
Form: F-1
Chunk 6
---
 receive one ADS when they could elect
the “zero exercise price” option in these circumstances to receive more ADSs than they would receive if they did pay an exercise price.

Additionally, the Warrants contain exercise price adjustments and adjustments to increase the number of ADSs issuable upon the exercise of the Warrants which will increase as the price of our ADSs falls further below the initial exercise price of such Warrants. Our ADSs are listed for trading on The Nasdaq Capital Market under the symbol “NCNA”. Each ADS represents twenty-five ordinary shares, nominal value £0.0004 per share. The ADSs may be evidenced by American Depositary Receipts, or ADRs. The last reported sale price of our ADSs on The Nasdaq Capital Market on April 22 , 2025 was $0.78 per ADS. All ADS, Warrant and Pre-FundedWarrant numbers are based on an assumed combined public offering price of $0.81 per ADS and the accompanying Warrants, based on the closing price of the Company’s ADSs on April 21, 2025 as reported on The Nasdaq Capital Market. The actual combined public offering price per ADS and accompanying Warrants, and per Pre-FundedWarrant and accompanying Warrants, will be fixed for the duration of this offering and will be determined between us and the purchasers based on market conditions at the time of pricing, and may be at a discount to the then current market price of our ADSs. The recent market price used throughout this prospectus may not be indicative of the actual combined public offering price. The actual combined public offering price may be based upon a number of factors, including our history and our prospects, the industry in which we operate, our past and present operating results, the previous experience of our executive officers and the general condition of the securities markets at the time of this offering. There is no established public trading market for the Warrants or Pre-FundedWarrants, and we do not expect a market for the Warrants or the Pre-FundedWarrants to develop. We do not intend to list the Warrants or Pre-FundedWarrants on The Nasdaq Capital Market, any other national securities exchange or any other trading system. Without an active trading market, the liquidity of the Warrants and the Pre-FundedWarrants will be limited. We anticipate that the ADSs to be issued upon exercise of the Warrants and the Pre-Funded Warrants will trade on The Nasdaq Capital Market. We have engaged L